BMO Capital Maintains Outperform on CareTrust REIT, Lowers Price Target to $45
Benzinga Newsdesk 4 weeks ago
Analyst RatingsNewsPrice Target
BMO Capital analyst Juan Sanabria maintains CareTrust REIT (NYSE:CTRE) with a Outperform and lowers the price target from $47 to $45.
BMO Capital analyst Juan Sanabria maintains CareTrust REIT (NYSE:CTRE) with a Outperform and lowers the price target from $47 to $45.